Bavarian Nordic’s monkeypox shot is making it a hot stock again
The biotech firm’s shares are soaring as the monkeypox outbreak continues to spread worldwide.
By Jonas Ekblom and Christian Wienberg, bloomberg
Bavarian Nordic A/S is having a bit of a meme-stock moment, with retail traders buying up shares in the monkeypox vaccine maker as cases of the virus steadily rise.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Bavarian Nordic CFO: More monkeypox orders may follow
For subscribers
.jpg&w=384&q=75)
